UCP2 and Hyperglycemia: In the presence of chronic hyperglycemia (glucotoxicity), the uncoupling protein 2 (UCP2) expression in beta cells is increased, and this event is associated with a reduction in the ratio of ATP to ADP, thus inhibiting glucose-stimulated insulin secretion (GSIS), which contributes to the development of T2DM (2–4).